Medline references for "DHEA and tumourigenesis"

• J Clin Endocrinol Metab 1975 Mar;40(3):373-9: Poortman J; Prenen JA; Schwarz F; Thijssen JH
  Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
  
• J Clin Endocrinol Metab 1978 Oct;47(4):717-24: Samojlik E; Santen RJ
  Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
  
• Pediatrics 1985 Sep;76(3):437-44: Lee PD; Winter RJ; Green OC
  Virilizing adrenocortical tumors in childhood: eight cases and a review of the literature.
  
• Toxicol Pathol 1986;14(3):357-62: Schwartz AG; Pashko L; Whitcomb JM
  Inhibition of tumor development by dehydroepiandrosterone and related steroids.
  
• Cancer Surv 1986;5(3):585-95: Vermeulen A
  Human mammary cancer as a site of sex steroid metabolism.
  
• Adv Enzyme Regul 1987;26 (1):355-82: Gordon GB; Shantz LM; Talalay P
  Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
  
• Int J Dev Biol 1989 Mar;33(1):173-6: Saksela E; Jaattela M
  Tumor necrosis factor in the human fetoplacentary unit.
  
• Helv Chir Acta 1989 Aug;56(3):307-14: Burgi U
  [Normal and pathologic endocrinology of the adrenal glands]
  
• JAMA 1987 Nov 13;258(18):2558-61: Kamilaris TC; De Bold CR; Manolas KJ; Hoursanidis A; Panageas S; Yiannatos J
  Testosterone-secreting adrenal adenoma in a peripubertal girl.
  
• Obstet Gynecol 1989 May;73(5 Pt 2):901-5: Haning RV Jr; Loughlin J; Shapiro SS
  Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
  
• Gan No Rinsho 1988 Jan;34(1):97-106: Kamiya T; Yasui T; Yokomori H; Nakamoto H; Maruyama T; Suzuki O; Ookawa H; Kiryu Y; Yasumura K; Kakumoto Y; et al
  [2 surgically treated cases of adrenocortical carcinoma producing steroid hormones without endocrinological symptoms--case report and a review of cases in the Japanese literature]
  
• Obstet Gynecol 1989 May;73(5 Pt 2):895-8: de Lima GR; de Lima OA; Baracat EC; Vasserman J; Burnier M Jr
  Virilizing Brenner tumor of the ovary: case report.
  
• Horm Res 1988;30(6):217-23: Sorgo W; Meyer D; Rodens K; Homoki J; Heinze E; Heymer B; Siebenmann R
  Testosterone-secreting adrenocortical tumor in a pubertal girl. Case report and review of the literature.
  
• Semin Oncol 1988 Apr;15(2 Suppl 1):53-61: Geller J; Albert J; Vik A
  Advantages of total androgen blockade in the treatment of advanced prostate cancer.
  
• Princess Takamatsu Symp 1990;21 (1):33-44: Estabrook RW; Milewich L; Prough RA
  Cytochrome P-450s as toxicogenic catalysts: the influence of dehydroepiandrosterone.
  
• Mutat Res 1992 Jun;267(2):251-5: Boone CW; Steele VE; Kelloff GJ
  Screening for chemopreventive (anticarcinogenic) compounds in rodents.
  
• Mol Cell Endocrinol 1991 Jul;78(3):C113-8: Labrie F
  Intracrinology.
  
• Int J Cancer 1992 Apr 1;50(6):854-8: Adams JB
  Human breast cancer: concerted role of diet, prolactin and adrenal C19-delta 5-steroids in tumorigenesis.
  
• Cleve Clin J Med 1990 Mar-Apr;57(2):161-6: Cumming DC
  Androgenesis and androdynamics in normal women.
  
• J Gastroenterol Hepatol 1991 Jan-Feb;6(1):81-9: Fettman MJ; Butler RN; McMichael AJ; Roberts-Thomson IC
  Metabolic phenotypes and colorectal neoplasia.
  
• J Clin Endocrinol Metab 1990 May;70(5):1280-4: Kirk JM; Perry LA; Shand WS; Kirby RS; Besser GM; Savage MO
  Female pseudohermaphroditism due to a maternal adrenocortical tumor.
  
• Cancer Res 1990 Jan 1;50(1):2-9: Boone CW; Kelloff GJ; Malone WE
  Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
  
• J Cell Biochem Suppl 1993;17G (1):73-9: Schwartz AG; Pashko LL
  Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs.
  
• Nippon Ronen Igakkai Zasshi 1994 Feb;31(2):85-95: Namiki M
  [Aged people and stress]
  
• Lancet 1994 Jun 11;343(8911):1479-81: Ebeling P; Koivisto VA
  Physiological importance of dehydroepiandrosterone.
  
• Clin Invest Med 1993 Dec;16(6):475-92: Labrie F; Belanger A; Dupont A; Luu-The V; Simard J; Labrie C
  Science behind total androgen blockade: from gene to combination therapy.
  
• J Steroid Biochem Mol Biol 1993 Apr;45(1-3):167-72: Pasqualini JR
  Role of androgens in breast cancer.
  
• Breast Cancer Res Treat 1992;24(1):1-9: Enriori CL; Novelli JE; Cremona M del C; Hirsig RJ; Enriori PJ
  Biochemical study of cyst fluid in human breast cystic disease: a review.
  
• J Steroid Biochem Mol Biol 1994 Jun;49(4-6):333-9: Angeli A; Dogliotti L; Naldoni C; Orlandi F; Puligheddu B; Caraci P; Bucchi L; Torta M; Bruzzi P
  Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk.